{"url_path":"/sec/cgtx/8-k/2026-06-04/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-04","source_url":"https://www.sec.gov/Archives/edgar/data/1455365/0001104659-26-070345-index.html","accession_number":"0001104659-26-070345","cik":"0001455365","ticker":"CGTX","issuer_name":"COGNITION THERAPEUTICS INC","edgar_url":"https://www.sec.gov/Archives/edgar/data/1455365/0001104659-26-070345-index.html","primary_entity_key":"0001455365","primary_entity_name":"COGNITION THERAPEUTICS INC"},"word_count":88,"has_tables":true,"body_markdown":"**Item 9.01 Financial Statements and Exhibits.**\n\n \n\n(d) Exhibits\n\n \n\nThe following exhibits\nare being furnished herewith:\n\n \n\n**Exhibit\nNo.**\n \n**Document**\n\n[99.1](tm2616896d1_ex99-1.htm)\n \n[Investor presentation of\nCognition Therapeutics, Inc.](tm2616896d1_ex99-1.htm)\n\n104\n \nCover Page Interactive\nData File (embedded within the Inline XBRL document)\n\n \n\n \n\n \n\n \n\n**SIGNATURES**\n\n \n\nPursuant to the requirements of the Securities\nExchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n \n**COGNITION THERAPEUTICS, INC.**\n\nDate: June 4, 2026\n \n \n\n \nBy:\n*/s/ Lisa Ricciardi*\n\n \nName:\nLisa Ricciardi\n\n \nTitle:\nPresident and Chief Executive Officer"}